NSE · NEULANDLAB.NS
Neuland Laboratories Limited
₹19,580.00+₹300.00 (+1.56%)
Neuland Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 19.17% below the high.
Loading market information…
NSE · UNICHEMLAB.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:11 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Unichem Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 29.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Unichem Laboratories Limited’s forward annual dividend is ₹4.00 per share, paid annual. The forward yield is 0.82% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Unichem Laboratories Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Unichem Laboratories Limited is an international pharmaceutical company engaged in the development, manufacturing, and commercialization of a wide array of medicinal products. The firm's portfolio features finished pharmaceutical formulations designed to treat numerous health conditions, including those related to gastroenterology, cardiovascular health, diabetes, mental health, neurological disorders, bacterial and other infectious diseases, and pain relief. Beyond these formulations, Unichem also provides active pharmaceutical ingredients (APIs) and offers contract manufacturing solutions. This enterprise was established in 1944 and operates from its corporate headquarters in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹19,580.00+₹300.00 (+1.56%)
Neuland Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 19.17% below the high.
₹798.20+₹3.35 (+0.42%)
Alembic Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 20.1% below the high.
₹925.10-₹20.90 (-2.21%)
Jubilant Pharmova Limited’s quoted price sits in the lower half of its reported 52-week range, 21.8% below the high.
₹1,037.30-₹60.20 (-5.49%)
Strides Pharma Science Limited’s quoted price sits in the upper half of its reported 52-week range, 17.73% below the high.
₹646.90-₹34.00 (-4.99%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.74% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹415.40-₹3.40 (-0.81%)
Gufic Biosciences Limited’s quoted price sits in the upper half of its reported 52-week range, 11.03% below the high.
₹948.40+₹1.90 (+0.2%)
Sakar Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 22.82% below the high.
